Journal of Cardiac Failure
Volume 16, Issue 11 , Pages 855-858 , November 2010

NHLBI’s Program for VAD Therapy for Moderately Advanced Heart Failure: The REVIVE-IT Pilot Trial

  • J. Timothy Baldwin, PhD

      Affiliations

    • Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD
    • Corresponding Author InformationReprint requests: J. Timothy Baldwin, PhD, Deputy Chief/Program Director, Advanced Technologies & Surgery Branch, Basic and Early Technology Research Program, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Two Rockledge Centre, Room 8206, 6701 Rockledge Drive, Bethesda, MD 20892-7940. Tel: (301) 435-0513; Fax: (301) 480-1454.
    • ,
  • Douglas L. Mann, MD

      Affiliations

    • Cardiovascular Division, Washington University School of Medicine, St. Louis, MO

Received 5 April 2010 ,Revised 24 May 2010 ,Accepted 15 June 2010.

References 

  1. Nabel EG. Shaping the future of research: the NHLBI strategic plan. Circ Res. 2007;101:849–850
  2. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–1443
  3. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29:1–10
  4. Lahpor JR. State of the art: implantable ventricular assist devices. Curr Opin Organ Transplant. 2009;14:554–559
  5. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–2251

 See page 858 for disclosure information.

PII: S1071-9164(10)00712-8

doi: 10.1016/j.cardfail.2010.06.414

Journal of Cardiac Failure
Volume 16, Issue 11 , Pages 855-858 , November 2010

Article Tools